Stage IIIB Colorectal Cancer AJCC v8

Quiénes somos

  • 5 de abril de 2022
    Una vacuna (Ad5.F35-hGCC-PADRE) para el tratamiento del adenocarcinoma gastrointestinal
  • 5 de abril de 2022
    Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations
  • 5 de abril de 2022
    Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer
  • 5 de abril de 2022
    Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer